Verified Nov 2026
Other
·

Lebanon, New Jersey
·
Since
Recordati Rare Diseases Inc. is a pharmaceutical company headquartered in Lebanon, New Jersey, operating as part of the Recordati Group. The company employs 200 to 500 people and develops and commercializes therapies for rare and ultra-rare diseases, including inborn errors of metabolism, lysosomal storage disorders, and rare endocrine and hematologic conditions. It serves the medical and industrial equipment sectors, providing patient support and education alongside its therapeutic portfolio.
Recordati Rare Diseases Inc. at a glance
Employees
200-500
Headquarters
Lebanon, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Recordati Rare Diseases Inc. is a pharmaceutical company headquartered in Lebanon, New Jersey, operating as part of the Recordati Group. The company employs 200 to 500 people and develops and commercializes therapies for rare and ultra-rare diseases, including inborn errors of metabolism, lysosomal storage disorders, and rare endocrine and hematologic conditions. It serves the medical and industrial equipment sectors, providing patient support and education alongside its therapeutic portfolio.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Lebanon, New Jersey |
Employees | 200-500 |
What Recordati Rare Diseases Inc. makes
The company specializes in therapies for conditions such as cystinosis, acute intermittent porphyria, and Cushing's syndrome, supported by patient advocacy partnerships and clinical research programs.
Latest developments
2026-11-12 — Recordati and Partners to Present New Evidence and Guidance in Rare Hematologic Diseases at American Society of Hematology (ASH) Annual Meeting and Exposition (prnewswire.com)
2026-06-25 — Ionis bags $30M from Recordati for ex-US rare disease rights (fiercebiotech.com)
2026-03-05 — Recordati Rare Diseases impulsa su crecimiento con foco en diagnóstico y acceso | UEstudio (expansion.com)
2026-01-29 — RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO (globenewswire.com)
2025-12-19 — We have a new home in Munich! | Recordati Rare Diseases (linkedin.com)
2025-12-18 — レコルダティ、インレビック®の日本における製造販売権利取得に合意 – Recordati Rare Diseases (recordatirarediseases.com)
Company details
Recordati Rare Diseases operates as a subsidiary of the Recordati Group and maintains a commitment to enhancing diagnosis and treatment access for patients with ultra-rare conditions. Recordati Rare Diseases Inc. has an estimated 200-500 employees, and is headquartered in Lebanon, New Jersey.
Frequently asked questions
What does Recordati Rare Diseases Inc. do?
Recordati Rare Diseases Inc. is a pharmaceutical company headquartered in Lebanon, New Jersey, operating as part of the Recordati Group. The company employs 200 to 500 people and develops and commercializes therapies for rare and ultra-rare diseases, including inborn errors of metabolism, lysosomal storage disorders, and rare endocrine and hematologic conditions. It serves the medical and industrial equipment sectors, providing patient support and education alongside its therapeutic portfolio.
Where is Recordati Rare Diseases Inc. headquartered?
Recordati Rare Diseases Inc. is headquartered in Lebanon, New Jersey (100 Corporate Dr, Lebanon, New Jersey, 08833).
How big is Recordati Rare Diseases Inc.?
Recordati Rare Diseases Inc. has an estimated 200-500 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
